Review



mouse macsplex ev kit 130 122 211 miltenyi biotec germany  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Miltenyi Biotec mouse macsplex ev kit 130 122 211 miltenyi biotec germany
    Mouse Macsplex Ev Kit 130 122 211 Miltenyi Biotec Germany, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+ev+io+kit/MACSPlex+EV+Kit+IO%2C+mouse/pmc13360959-87-25-30
    Average 97 stars, based on 12 article reviews
    mouse macsplex ev kit 130 122 211 miltenyi biotec germany - by Bioz Stars, 2026-09
    97/100 stars

    Images



    Similar Products

    97
    Miltenyi Biotec mouse macsplex ev kit 130 122 211 miltenyi biotec germany
    Mouse Macsplex Ev Kit 130 122 211 Miltenyi Biotec Germany, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+ev+io+kit/MACSPlex+EV+Kit+IO%2C+mouse/pmc13360959-87-25-30
    Average 97 stars, based on 1 article reviews
    mouse macsplex ev kit 130 122 211 miltenyi biotec germany - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec macsplex ev kit io
    Experimental workflow overview. This schematic illustrates the experimental design used to profile extracellular vesicles (EVs) derived from U87 glioblastoma cells cultured <t>under</t> <t>2D</t> monolayer and eroid conditions. A , expansion of U-87 MG glioblastoma cells in T225 flasks prior to experimental setup. B , 2D experimental arm: cells cultured in T75 flasks and treated with DMSO, temozolomide (TMZ) 100 μM, or TMZ 200 μM, followed by EV isolation and cell harvesting. C , 3D-spheroid experimental arm: cells seeded in ultra-low attachment (ULA) plates and treated as in ( B ), with subsequent EV isolation and spheroid harvesting. D , EV and cell characterization by Annexin V/PI cell death assay, fluorescence microscopy, transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), silver-stained SDS-PAGE, western blotting, and <t>MACSPlex</t> EV flow cytometry assay. E , protein extraction from EVs and cells, followed by proteomic profiling using nano-liquid chromatography tandem mass spectrometry (nLC-ESI-MS/MS). F , differential expressions and functional analysis, including heatmap clustering and identification of GBM-associated protein families (e.g., methyltransferases). G , cross-referencing of selected proteins with The Cancer Genome Atlas (TCGA) for prognostic relevance. H , EV isolation pipeline combining ultrafiltration and size-exclusion chromatography (SEC) for purification of vesicles from conditioned media.
    Macsplex Ev Kit Io, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+ev+io+kit/MACSPlex+EV+Kit+IO%2C+human/pmc13393710-81-11-18
    Average 97 stars, based on 1 article reviews
    macsplex ev kit io - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec human macsplex ev kit io
    Multiplex bead-based EV <t>flow</t> <t>cytometry</t> assay for surface markers. EVs enriched from UHPi and IVIg by SEC and dUC. Surface marker profiles were measured using Miltenyi <t>MACSPlex</t> EV kit IO with MESF-calibrated flow cytometry. (A) Heatmap and hierarchical clustering of MACSPlex markers in UHPi EVs, IVIg EVs, and bead/antibody controls (left). Median APC intensity (MESF, background-subtracted) of mixed tetraspanin antibodies (CD9/CD81/CD63) on EVs captured by 39 marker beads (middle/right). (B) Enlarged values for the tetraspanins (CD9, CD63, and CD81), HLA markers (HLA-ABC and HLA-DR, DP,DQ), platelet markers (CD42a, CD41b, and CD62p), and stemness markers (CD29, ROR1, CD24, CD326, CD133/1). dUC, differential ultracentrifugation; EV, extracellular vesicles; Human Leukocyte Antigens; HLA; IVIg, intravenous immunoglobulin; MESF, Molecular Equivalents of Soluble Fluorophore; SEC, size-exclusion chromatography; UHPi, individual unprocessed human plasma.
    Human Macsplex Ev Kit Io, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+ev+io+kit/MACSPlex+EV+Kit+IO%2C+human/bio_rxiv__64898__2026__04__29__721601-65-23-28
    Average 97 stars, based on 1 article reviews
    human macsplex ev kit io - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec germany catalog 130 108 813
    Multiplex bead-based EV <t>flow</t> <t>cytometry</t> assay for surface markers. EVs enriched from UHPi and IVIg by SEC and dUC. Surface marker profiles were measured using Miltenyi <t>MACSPlex</t> EV kit IO with MESF-calibrated flow cytometry. (A) Heatmap and hierarchical clustering of MACSPlex markers in UHPi EVs, IVIg EVs, and bead/antibody controls (left). Median APC intensity (MESF, background-subtracted) of mixed tetraspanin antibodies (CD9/CD81/CD63) on EVs captured by 39 marker beads (middle/right). (B) Enlarged values for the tetraspanins (CD9, CD63, and CD81), HLA markers (HLA-ABC and HLA-DR, DP,DQ), platelet markers (CD42a, CD41b, and CD62p), and stemness markers (CD29, ROR1, CD24, CD326, CD133/1). dUC, differential ultracentrifugation; EV, extracellular vesicles; Human Leukocyte Antigens; HLA; IVIg, intravenous immunoglobulin; MESF, Molecular Equivalents of Soluble Fluorophore; SEC, size-exclusion chromatography; UHPi, individual unprocessed human plasma.
    Germany Catalog 130 108 813, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+ev+io+kit/MACSPlex+EV+Kit+IO%2C+human/pmc13115070-110-17-13
    Average 97 stars, based on 1 article reviews
    germany catalog 130 108 813 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec macsplex ev io kit
    Multiplex bead-based EV <t>flow</t> <t>cytometry</t> assay for surface markers. EVs enriched from UHPi and IVIg by SEC and dUC. Surface marker profiles were measured using Miltenyi <t>MACSPlex</t> EV kit IO with MESF-calibrated flow cytometry. (A) Heatmap and hierarchical clustering of MACSPlex markers in UHPi EVs, IVIg EVs, and bead/antibody controls (left). Median APC intensity (MESF, background-subtracted) of mixed tetraspanin antibodies (CD9/CD81/CD63) on EVs captured by 39 marker beads (middle/right). (B) Enlarged values for the tetraspanins (CD9, CD63, and CD81), HLA markers (HLA-ABC and HLA-DR, DP,DQ), platelet markers (CD42a, CD41b, and CD62p), and stemness markers (CD29, ROR1, CD24, CD326, CD133/1). dUC, differential ultracentrifugation; EV, extracellular vesicles; Human Leukocyte Antigens; HLA; IVIg, intravenous immunoglobulin; MESF, Molecular Equivalents of Soluble Fluorophore; SEC, size-exclusion chromatography; UHPi, individual unprocessed human plasma.
    Macsplex Ev Io Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/macsplex+ev+io+kit/MACSPlex+EV+Kit+IO%2C+human/pmc12996455-46-10-8
    Average 97 stars, based on 1 article reviews
    macsplex ev io kit - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    Image Search Results


    Experimental workflow overview. This schematic illustrates the experimental design used to profile extracellular vesicles (EVs) derived from U87 glioblastoma cells cultured under 2D monolayer and eroid conditions. A , expansion of U-87 MG glioblastoma cells in T225 flasks prior to experimental setup. B , 2D experimental arm: cells cultured in T75 flasks and treated with DMSO, temozolomide (TMZ) 100 μM, or TMZ 200 μM, followed by EV isolation and cell harvesting. C , 3D-spheroid experimental arm: cells seeded in ultra-low attachment (ULA) plates and treated as in ( B ), with subsequent EV isolation and spheroid harvesting. D , EV and cell characterization by Annexin V/PI cell death assay, fluorescence microscopy, transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), silver-stained SDS-PAGE, western blotting, and MACSPlex EV flow cytometry assay. E , protein extraction from EVs and cells, followed by proteomic profiling using nano-liquid chromatography tandem mass spectrometry (nLC-ESI-MS/MS). F , differential expressions and functional analysis, including heatmap clustering and identification of GBM-associated protein families (e.g., methyltransferases). G , cross-referencing of selected proteins with The Cancer Genome Atlas (TCGA) for prognostic relevance. H , EV isolation pipeline combining ultrafiltration and size-exclusion chromatography (SEC) for purification of vesicles from conditioned media.

    Journal: Molecular & Cellular Proteomics : MCP

    Article Title: Extracellular Vesicles From Glioblastoma Cells Reflect 2D vs. 3D Culture Adaptation and Resistance to Temozolomide

    doi: 10.1016/j.mcpro.2026.101610

    Figure Lengend Snippet: Experimental workflow overview. This schematic illustrates the experimental design used to profile extracellular vesicles (EVs) derived from U87 glioblastoma cells cultured under 2D monolayer and eroid conditions. A , expansion of U-87 MG glioblastoma cells in T225 flasks prior to experimental setup. B , 2D experimental arm: cells cultured in T75 flasks and treated with DMSO, temozolomide (TMZ) 100 μM, or TMZ 200 μM, followed by EV isolation and cell harvesting. C , 3D-spheroid experimental arm: cells seeded in ultra-low attachment (ULA) plates and treated as in ( B ), with subsequent EV isolation and spheroid harvesting. D , EV and cell characterization by Annexin V/PI cell death assay, fluorescence microscopy, transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), silver-stained SDS-PAGE, western blotting, and MACSPlex EV flow cytometry assay. E , protein extraction from EVs and cells, followed by proteomic profiling using nano-liquid chromatography tandem mass spectrometry (nLC-ESI-MS/MS). F , differential expressions and functional analysis, including heatmap clustering and identification of GBM-associated protein families (e.g., methyltransferases). G , cross-referencing of selected proteins with The Cancer Genome Atlas (TCGA) for prognostic relevance. H , EV isolation pipeline combining ultrafiltration and size-exclusion chromatography (SEC) for purification of vesicles from conditioned media.

    Article Snippet: EV samples from 2D and 3D cultures were analyzed with the MACSPlex EV Kit IO (for immuno-oncology) (#130-108-813) (Miltenyi Biotec).

    Techniques: Derivative Assay, Cell Culture, Isolation, Cell Harvesting, Cell Characterization, Fluorescence, Microscopy, Transmission Assay, Electron Microscopy, Staining, SDS Page, Western Blot, Flow Cytometry, Protein Extraction, Liquid Chromatography, Mass Spectrometry, Tandem Mass Spectroscopy, Functional Assay, Size-exclusion Chromatography, Purification

    Characterization of EV protein profiles from U87 2D and 3D cultures. A , multiplex flow cytometry using the MACSPlex EV kit was used to profile surface markers of EVs derived from U87 cells cultured under 2D and 3D conditions. CD44 was consistently detected and enriched across conditions, particularly in TMZ-treated samples. The integrins CD29 and CD49e—subunits of the α5β1 integrin heterodimer—were robustly expressed in both 2D and 3D EVs, highlighting their potential role in EV-mediated adhesion and signaling. B , silver-stained SDS-PAGE showing global protein profiles of cell lysates and EVs from 2D and 3D cultures. Distinct banding patterns reflect culture-specific proteomic signatures and successful protein isolation. C , Western blot analysis confirms the presence of established EV-associated proteins, including CD81 and CD44. GAPDH, were used as controls and were detected predominantly in cell lysates, supporting the purity of the EV preparations and absence of major cellular contamination.

    Journal: Molecular & Cellular Proteomics : MCP

    Article Title: Extracellular Vesicles From Glioblastoma Cells Reflect 2D vs. 3D Culture Adaptation and Resistance to Temozolomide

    doi: 10.1016/j.mcpro.2026.101610

    Figure Lengend Snippet: Characterization of EV protein profiles from U87 2D and 3D cultures. A , multiplex flow cytometry using the MACSPlex EV kit was used to profile surface markers of EVs derived from U87 cells cultured under 2D and 3D conditions. CD44 was consistently detected and enriched across conditions, particularly in TMZ-treated samples. The integrins CD29 and CD49e—subunits of the α5β1 integrin heterodimer—were robustly expressed in both 2D and 3D EVs, highlighting their potential role in EV-mediated adhesion and signaling. B , silver-stained SDS-PAGE showing global protein profiles of cell lysates and EVs from 2D and 3D cultures. Distinct banding patterns reflect culture-specific proteomic signatures and successful protein isolation. C , Western blot analysis confirms the presence of established EV-associated proteins, including CD81 and CD44. GAPDH, were used as controls and were detected predominantly in cell lysates, supporting the purity of the EV preparations and absence of major cellular contamination.

    Article Snippet: EV samples from 2D and 3D cultures were analyzed with the MACSPlex EV Kit IO (for immuno-oncology) (#130-108-813) (Miltenyi Biotec).

    Techniques: Multiplex Assay, Flow Cytometry, Derivative Assay, Cell Culture, Staining, SDS Page, Isolation, Western Blot

    Multiplex bead-based EV flow cytometry assay for surface markers. EVs enriched from UHPi and IVIg by SEC and dUC. Surface marker profiles were measured using Miltenyi MACSPlex EV kit IO with MESF-calibrated flow cytometry. (A) Heatmap and hierarchical clustering of MACSPlex markers in UHPi EVs, IVIg EVs, and bead/antibody controls (left). Median APC intensity (MESF, background-subtracted) of mixed tetraspanin antibodies (CD9/CD81/CD63) on EVs captured by 39 marker beads (middle/right). (B) Enlarged values for the tetraspanins (CD9, CD63, and CD81), HLA markers (HLA-ABC and HLA-DR, DP,DQ), platelet markers (CD42a, CD41b, and CD62p), and stemness markers (CD29, ROR1, CD24, CD326, CD133/1). dUC, differential ultracentrifugation; EV, extracellular vesicles; Human Leukocyte Antigens; HLA; IVIg, intravenous immunoglobulin; MESF, Molecular Equivalents of Soluble Fluorophore; SEC, size-exclusion chromatography; UHPi, individual unprocessed human plasma.

    Journal: bioRxiv

    Article Title: Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy

    doi: 10.64898/2026.04.29.721601

    Figure Lengend Snippet: Multiplex bead-based EV flow cytometry assay for surface markers. EVs enriched from UHPi and IVIg by SEC and dUC. Surface marker profiles were measured using Miltenyi MACSPlex EV kit IO with MESF-calibrated flow cytometry. (A) Heatmap and hierarchical clustering of MACSPlex markers in UHPi EVs, IVIg EVs, and bead/antibody controls (left). Median APC intensity (MESF, background-subtracted) of mixed tetraspanin antibodies (CD9/CD81/CD63) on EVs captured by 39 marker beads (middle/right). (B) Enlarged values for the tetraspanins (CD9, CD63, and CD81), HLA markers (HLA-ABC and HLA-DR, DP,DQ), platelet markers (CD42a, CD41b, and CD62p), and stemness markers (CD29, ROR1, CD24, CD326, CD133/1). dUC, differential ultracentrifugation; EV, extracellular vesicles; Human Leukocyte Antigens; HLA; IVIg, intravenous immunoglobulin; MESF, Molecular Equivalents of Soluble Fluorophore; SEC, size-exclusion chromatography; UHPi, individual unprocessed human plasma.

    Article Snippet: EVs isolated from UHPi, UHPp, and IVIg were subjected to immune profiling for 39 known EV surface proteins by flow cytometry using the human MACSPlex EV kit IO (Miltenyi Biotec, Auburn, CA) and detected by flow cytometry (Cytek Aurora, Cytek Biosciences) with fluorescence calibration using Molecular Equivalents of Soluble Fluorophore (MESF) standards (Quantum APC MESF Beads, Bangs Laboratories) as previously described ( ; ).

    Techniques: Multiplex Assay, Flow Cytometry, Marker, Size-exclusion Chromatography, Clinical Proteomics